Complications and challenges associated with polycystic ovary syndrome: current perspectives

References

• AzzizRWoodsKSReynaRKeyTJKnochenhauerESYildizBOThe prevalence and features of the polycystic ovary syndrome in an unselected populationJ Clin Endocrinol Metab20048962745274915181052
   PubMed Web of Science ®Google Scholar
• KauffmanRPBakerTEBakerVMDiMarinoPCastracaneDEndocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteriaAm J Obstet Gynecol20081986670.e1670.e1018355776
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEKouliCRBergieleATA survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profileJ Clin Endocrinol Metab199984114006401110566641
   PubMed Web of Science ®Google Scholar
• AsuncionMCalvoRMSan MillanJLSanchoJAvilaSEscobar-MorrealeHFA prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from SpainJ Clin Endocrinol Metab20008572434243810902790
   PubMed Web of Science ®Google Scholar
• MarchWAMooreVMWillsonKJPhillipsDINormanRJDaviesMJThe prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteriaHum Reprod201025254455119910321
   PubMed Web of Science ®Google Scholar
• SteinIFLeventhalMIAmenorrhea associated with bilateral polycystic ovariesAm J Obstet Gynecol193529181191
   Google Scholar
• ZawadskiJKDunaifADiagnostic criteria for polycystic ovary syndrome; toward a rational approachDunaifAGivensJRHaseltineFPPolycystic Ovary SyndromeBoston MABlackwell Scientific1992377384
   Google Scholar
• Rotterdam ESHRE/ASRM–Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Hum Reprod2004191414714688154
   PubMed Web of Science ®Google Scholar
• GoverdeAJvan KoertAJEijkemansMJIndicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteriaHum Reprod200924371071719095675
   PubMed Web of Science ®Google Scholar
• MoranLJMissoMLWildRANormanRJImpaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201016434736320159883
   PubMed Web of Science ®Google Scholar
• YildizBOBozdagGYapiciZEsinlerIYaraliHPrevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteriaHum Reprod201227103067307322777527
   PubMed Web of Science ®Google Scholar
• AzzizRCarminaEDewaillyDPositions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guidelineJ Clin Endocrinol Metab200691114237424516940456
   PubMed Web of Science ®Google Scholar
• FauserBCTarlatzisBCRebarRWConsensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertil Steril2012971283822153789
   PubMed Web of Science ®Google Scholar
• National Institutes of Health (NIH)Evidence-based Methodology Workshop on Polycystic Ovary Syndrome123–52012 Available from: https://prevention.nih.gov/docs/programs/pcos/finelreport.pdf
   Google Scholar
• ConwayGDewaillyDDiamanti-KandarakisEThe polycystic ovary syndrome: a position statement from the European Society of EndocrinologyEur J Endocrinol2014171412924743401
   PubMed Web of Science ®Google Scholar
• LegroRSArslanianSAEhrmannDADiagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab201398124565459224151290
   PubMed Web of Science ®Google Scholar
• OrioFPalombaSReproductive endocrinology: new guidelines for the diagnosis and treatment of PCOSNat Rev Endocrinol201410313013224322653
   PubMed Web of Science ®Google Scholar
• WeltCKCarminaEClinical review: lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopauseJ Clin Endocrinol Metab201398124629463824064685
   PubMed Web of Science ®Google Scholar
• HullMGEpidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studiesGynecol Endocrinol198712352453140583
   PubMedGoogle Scholar
• BalenAHConwayGSKaltsasGPolycystic ovary syndrome: the spectrum of the disorder in 1741 patientsHum Reprod199510210721118567849
   PubMed Web of Science ®Google Scholar
• TianLShenHLuQNormanRJWangJInsulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatmentJ Clin Endocrinol Metab20079241430143317244790
   PubMed Web of Science ®Google Scholar
• JungheimESLanzendorfSEOdemRRMoleyKHChangASRattsVSMorbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndromeFertil Steril200992125626118692801
   PubMed Web of Science ®Google Scholar
• JakubowiczDJEssahPASeppäläMReduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancyJ Clin Endocrinol Metab200489283383914764802
   PubMed Web of Science ®Google Scholar
• PalombaSRussoTOrioFJrUterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled studyHum Reprod200621112823282916835214
   PubMed Web of Science ®Google Scholar
• PalombaSOrioFJrFalboARussoTTolinoAZulloFEffects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndromeFertil Steril20068661694170117074337
   PubMed Web of Science ®Google Scholar
• TeissierMPChableHPaulhacSAubardYComparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundabilityHum Reprod200015122471247711098013
   PubMed Web of Science ®Google Scholar
• PalombaSFalboARussoTOrioFTolinoAZulloFSystemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory responseHum Reprod20102541005101320106839
   PubMed Web of Science ®Google Scholar
• WoodJRDumesicDAAbbottDHStraussJF3rdMolecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysisJ Clin Endocrinol Metab200792270571317148555
   PubMed Web of Science ®Google Scholar
• DahlgrenEJohanssonSLindstedtGWomen with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormonesFertil Steril19925735055131740195
   PubMed Web of Science ®Google Scholar
• CibulaDCifkovaRFantaMPoledneRZivnyJSkibovaJIncreased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndromeHum Reprod20001578578910739820
   PubMed Web of Science ®Google Scholar
• WildSPierpointTMcKeiguePJacobsHCardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort studyClin Endocrinol (Oxf)20005259560010792339
   PubMed Web of Science ®Google Scholar
• HudecovaMHolteJOlovssonMSundström PoromaaILong-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserveHum Reprod20092451176118319168874
   PubMed Web of Science ®Google Scholar
• KorhonenSHippelainenMVanhalaMHeinonenSNiskanenLThe androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based studyFertil Steril2003791327133412798879
   PubMed Web of Science ®Google Scholar
• EltingMWKorsenTJRekers-MombargLTSchoemakerJWomen with polycystic ovary syndrome gain regular menstrual cycles when ageingHum Reprod200015242810611183
   PubMed Web of Science ®Google Scholar
• KalraSKRatcliffebSJDokrasnAIs the fertile windows extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rateFertil Steril2013100120821323557762
   PubMed Web of Science ®Google Scholar
• HeijnenEMEijkemansMJHughesEGLavenJSMacklonNSFauserBCA meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndromeHum Reprod Update2006121132116123051
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertil Steril20048111925
   Web of Science ®Google Scholar
• PalombaSde WildeMAFalboAKosterMPHLa SalaGBFauserCJMPregnancy complications in women with polycystic ovary syndrome: new clinical and pathophysiological insightsHum Reprod Update2015627dmv02926117684
   PubMed Web of Science ®Google Scholar
• BoomsmaCMEijkemansMJHughesEGVisserGHFauserBCMacklonNSA meta-analysis of pregnancy outcomes in women with polycystic ovary syndromeHum Reprod Update200612667368316891296
   PubMed Web of Science ®Google Scholar
• KjerulffLESanchez-RamosLDuffyDPregnancy outcomes in women with polycystic ovary syndrome: a metaanalysisAm J Obstet Gynecol20112046558e1558.e621752757
   PubMed Web of Science ®Google Scholar
• QinJZPangLHLiMJFanXJHuangRDChenHYObstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysisReprod Biol Endocrinol2013261156
   Google Scholar
• LiuLTongXJiangLLiTCZhouFZhangSA comparison of the miscarriage rate between women with and without polycystic ovarian syndrome undergoing IVF treatmentEur J Obstet Gynecol Reprod Biol2014176417818224680396
   PubMed Web of Science ®Google Scholar
• PalombaSChiossiGFalboALow-grade chronic inflammation in pregnant women with polycystic ovary syndromeJ Clin Endocrinol Metab20149982942295124873996
   PubMed Web of Science ®Google Scholar
• PalombaSFalboAChiossiGLipid profile in pregnant women with polycystic ovary syndromeSteroids201488364324945113
   PubMed Web of Science ®Google Scholar
• de WildeMAVeltman-VerhulstSMGoverdeAJPreconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndromeHum Reprod20142961327123624777850
   PubMed Web of Science ®Google Scholar
• NaverKVGrinstedJLarsenSOIncreased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemiaBJOG2014121557558124418062
   PubMed Web of Science ®Google Scholar
• HanARKimHOChaSWAdverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control studyClin Exp Reprod Med201138210310822384427
   PubMedGoogle Scholar
• RoosNKielerHSahlinLEkman-OrdebergGFalconerHStephanssonORisk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort studyBMJ2011343d630921998337
   PubMed Web of Science ®Google Scholar
• WildRACarminaEDiamanti-KandarakisEAssessment of cardiovascular risk and prevention of cardiovascular disease in women with the Polycystic Ovary Syndrome: a consensus statement by the Androgen Wxcess and Polycystic Ovary Syndrome (AE-PCOS) SocietyJ Clin Endocrinol Metab20109522038204920375205
   PubMed Web of Science ®Google Scholar
• ToulisKAGoulisDGMintzioriGMeta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndromeHum Reprod Update201117674176021628302
   PubMed Web of Science ®Google Scholar
• YusufSHawkenSOunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet2004364943893795215364185
   PubMed Web of Science ®Google Scholar
• Martins WdePSoaresGMVieiraCSdos ReisRMde SáMFFerrianiRACardiovascular risk markers in polycystic ovary syndrome in women with and without insulin resistanceRev Bras Ginecol Obstet200931311111619547885
   PubMedGoogle Scholar
• ScicchitanoPDentamaroICarbonaraRCardiovascular risk in women with PCOSInt J Endocrinol Metab201210461161823843832
   PubMedGoogle Scholar
• ChenMJYangWSYangJHChenCLHoHNYangYSRelationship between androgen levels and blood pressure in young women with polycystic ovary syndromeHypertension20074961442144717389259
   PubMed Web of Science ®Google Scholar
• HolteJGennarelliGBerneCBerghTLithellHElevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?Hum Reprod199611123288671152
   PubMed Web of Science ®Google Scholar
• LegroRSKunselmanARDunaifAPrevalence and predictors of dyslipidemia in women with polycystic ovary syndromeAm J Med2001111860761311755503
   PubMed Web of Science ®Google Scholar
• EssahPANestlerJECarminaEDifferences in dyslipidemia between American and Italian women with polycystic ovary syndromeJ Endocrinol Invest2008311354118296903
   PubMed Web of Science ®Google Scholar
• AustinMAKingMCVranizanKMKraussRMAtherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease riskCirculation19908224955062372896
   PubMed Web of Science ®Google Scholar
• RizzoMBerneisKLipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?J Atheroscler Thromb200512523723916205019
   PubMed Web of Science ®Google Scholar
• BrunzellJDAyyobiAFDyslipidemia in the metabolic syndrome and type 2 diabetes mellitusAm J Med200311524S28S14678862
   PubMed Web of Science ®Google Scholar
• ValkenburgOSteegers-TheunissenRPSmedtsHPA more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control studyJ Clin Endocrinol Metab200893247047618056772
   PubMed Web of Science ®Google Scholar
• ZhangJFanPLiuHBaiHWangYZhangFApolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOSHum Reprod20122782484249322674204
   PubMed Web of Science ®Google Scholar
• JoharatnamJBarberTMWebberLConwayGSMcCarthyMIFranksSDeterminants of dyslipidaemia in probands with polycystic ovary syndrome and their sistersClin Endocrinol (Oxford)2011746714719
   Web of Science ®Google Scholar
• LegroRSGnatukCLKunselmanARDunaifAChanges in glucose tolerance over time in women with polycystic ovary syndrome: a controlled studyJ Clin Endocrinol Metab20059063236324215797965
   PubMed Web of Science ®Google Scholar
• NormanRJMastersLMilnerCRWangJXDaviesMJRelative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndromeHum Reprod20011691995199811527911
   PubMed Web of Science ®Google Scholar
• WangETCalderon-MargalitRCedarsMIPolycystic ovary syndrome and risk for long-term diabetes and dyslipidemiaObstet Gynecol2011117161321173640
   PubMed Web of Science ®Google Scholar
• PuglieseDNicolettiGAndreulaCCicconeMTriggianiGCombined protein C deficiency and protein C activated resistance as a cause of caval, peripheral, and cerebral venous thrombosis – a case reportAngiology19984953994019591532
   PubMed Web of Science ®Google Scholar
• RidkerPMClinical application of C-reactive protein for cardiovascular disease detection and preventionCirculation2003107336336912551853
   PubMed Web of Science ®Google Scholar
• OhJYLeeJALeeHOhJYSungYAChungHSerum C-reactive protein levels in normal-weight polycystic ovary syndromeKorean J Intern Med200924435035519949734
   PubMedGoogle Scholar
• MöhligMSprangerJOsterhoffMThe polycystic ovary syndrome per se is not associated with increased chronic inflammationEur J Endocrinol2004150452553215080783
   PubMed Web of Science ®Google Scholar
• YaraliHYildirirAAybarFDiastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndromeFertil Steril200176351151611532474
   PubMed Web of Science ®Google Scholar
• SchachterMRazielAFriedlerSStrassburgerDBernORon-ElRInsulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteineHum Reprod200318472172712660262
   PubMed Web of Science ®Google Scholar
• LoverroGLorussoFMeiLDepaloRCormioGSelvaggiLThe plasma homocysteine levels are increased in polycystic ovary syndromeGynecol Obstet Invest200253315716212053100
   PubMed Web of Science ®Google Scholar
• WiltgenDSpritzerPMVariation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypesFertil Steril20109462493249620338557
   PubMed Web of Science ®Google Scholar
• SamyNHashimMSayedMSaidMClinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass indexDis Markers200926416317019729797
   PubMed Web of Science ®Google Scholar
• EltingMWKorsenTJSchoemakerJObesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndromeClin Endocrinol (Oxf)200155676777611895219
   PubMed Web of Science ®Google Scholar
• WildSPierpointTJacobsHMcKeiguePLong-term consequences of polycystic ovary syndrome: results of a 31 year follow-up studyHum Fertil (Camb)20003210110511844363
   PubMedGoogle Scholar
• WildRAGrubbBHartzAVan NortJJBachmanWBartholomewMClinical signs of androgen excess as risk factors for coronary artery diseaseFertil Steril19905422552592143147
   PubMed Web of Science ®Google Scholar
• BirdsallMAFarquharCMWhiteHDAssociation between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterizationAnn Intern Med1997126132358992921
   PubMed Web of Science ®Google Scholar
• DokrasACardiovascular disease risk in women with PCOSSteroids201378877377623624351
   PubMed Web of Science ®Google Scholar
• SprungVSAtkinsonGCuthbertsonDJEndothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studiesClin Endocrinol (Oxf)201378343844622775449
   PubMed Web of Science ®Google Scholar
• ParadisiGSteinbergHOHempflingAPolycystic ovary syndrome is associated with endothelial dysfunctionCirculation2001103101410141511245645
   PubMed Web of Science ®Google Scholar
• KravaritiMNakaKKKalantaridouSNPredictors of endothelial dysfunction in young women with polycystic ovary syndromeJ Clin Endocrinol Metab20059095088509515985492
   PubMed Web of Science ®Google Scholar
• MeyerMLMalekAMWildRAKorytkowskiMTTalbottEOCarotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201218211212622108382
   PubMed Web of Science ®Google Scholar
• AradYSpadaroLAGoodmanKNewsteinDGuerciADPrediction of coronary events with electron beam computed tomographyJ Am Coll Cardiol20003641253126011028480
   PubMed Web of Science ®Google Scholar
• ChristianRCDumesicDABehrenbeckTObergALSheedyPFFitzpatrickLAPrevalence and predictors of coronary artery calcification in women with polycystic ovary syndromeJ Clin Endocrinol Metab20038862562256812788855
   PubMed Web of Science ®Google Scholar
• TalbottEOGuzickDSSutton-TyrrellKHugh-PemuKPZborowskiJVRemsbergKEEvidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged womenArterioscler Thromb Vasc Biol200020112414242111073846
   PubMed Web of Science ®Google Scholar
• Luque-RamirezMMendieta-AzconaCAlvarez-BlascoFEscobar-MorrealeHFAndrogen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndromeHum Reprod200722123197320317933750
   PubMed Web of Science ®Google Scholar
• TalbottEOZborowskiJRagerJStragandJRIs there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?Vasc Health Risk Manag20084245346218561521
   PubMedGoogle Scholar
• SchmidtJLandin-WilhelmsenKBrännströmMDahlgrenECardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up studyJ Clin Endocrinol Metab201196123794380321956415
   PubMed Web of Science ®Google Scholar
• De GrootPCDekkersOMRomijnJADiebenSWHelmerhorstFMPCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysisHum Reprod Update201117449550021335359
   PubMed Web of Science ®Google Scholar
• AndersonSABarryJAHardimanPJRisk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysisInt J Cardiol2014176248648725096551
   PubMed Web of Science ®Google Scholar
• LimSSDaviesMJNormanRJMoranLJOverweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201218661863722767467
   PubMed Web of Science ®Google Scholar
• ChingHLBurkeVStuckeyBGQuality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiersClin Endocrinol (Oxf)200766337337917302871
   PubMed Web of Science ®Google Scholar
• GlueckCJDharashivkarSWangPObesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathyEur J Obstet Gynecol Reprod Biol2005122220621216219521
   PubMed Web of Science ®Google Scholar
• ChenXNiRMoYLiLYangDAppropriate BMI levels for PCOS patients in Southern ChinaHum Reprod20102551295130220172872
   PubMed Web of Science ®Google Scholar
• SteptoNKCassarSJohamAEWomen with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clampHum Reprod201328377778423315061
   PubMed Web of Science ®Google Scholar
• TeedeHJJohamAEPaulELongitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young womenObesity20132181526153223818329
   PubMed Web of Science ®Google Scholar
• BatesGWLegroRSLong-term management of Polycystic Ovarian Syndrome (PCOS)Mol Cel Endocrinol20133731–29197
   PubMed Web of Science ®Google Scholar
• CarminaEBucchieriSEspositoAAbdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistanceJ Clin Endocrinol Metab20079272500250517405838
   PubMed Web of Science ®Google Scholar
• CascellaTPalombaSDe SioIVisceral fat is associated with cardiovascular risk in women with polycystic ovary syndromeHum Reprod200823115315918024952
   PubMed Web of Science ®Google Scholar
• LordJThomasRFoxBAcharyaUWilkinTThe central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndromeBJOG2006113101203120916753044
   PubMed Web of Science ®Google Scholar
• PasqualiRCasimirriFVenturoliSBody fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndromeMetabolism19944367067138201958
   PubMed Web of Science ®Google Scholar
• VrbikovaJHainerVObesity and polycystic ovary syndromeObes Facts200921263520054201
   PubMed Web of Science ®Google Scholar
• SamSDunaifAPolycystic ovary syndrome: syndrome XX? TrendsEndocrinol Metab2003148365370
   Google Scholar
• Diamanti-KandarakisEDunaifAInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implicationsEndocr Rev2012336981103023065822
   PubMed Web of Science ®Google Scholar
• TosiFDi SarraDKaufmanJMTotal body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndromeJ Clin Endocrinol Metab2015100266166925393642
   PubMed Web of Science ®Google Scholar
• AlbertiKGZimmetPShawJInternational Diabetes Federation: a consensus on type 2 diabetes preventionDiabet Med200724545146317470191
   PubMed Web of Science ®Google Scholar
• GambineriAPattonLAltieriPPolycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective studyDiabetes20126192369237422698921
   PubMed Web of Science ®Google Scholar
• DaanNMLouwersYVKosterMPCardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?Fertil Steril201410251444145125239303
   PubMed Web of Science ®Google Scholar
• ApridonidzeTEssahPAIuornoMJNestlerJEPrevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndromeJ Clin Endocrinol Metab20059041929193515623819
   PubMed Web of Science ®Google Scholar
• JovanovicVPCarminaELoboRANot all women diagnosed with PCOS share the same cardiovascular risk profilesFertil Steril201094382683219501355
   PubMed Web of Science ®Google Scholar
• MoranLTeedeHMetabolic features of the reproductive phenotypes of polycystic ovary syndromeHum Reprod Update200915447748819279045
   PubMed Web of Science ®Google Scholar
• MoranLJNormanRJTeedeHJMetabolic risk in PCOS: phenotype and adiposity impactTrends Endocrinol Metab201526313614325591984
   PubMed Web of Science ®Google Scholar
• MoranLJStraussBJTeedeHJDiabetes risk score in the diagnostic categories of polycystic ovary syndromeFertil Steril20119551742174821316662
   PubMed Web of Science ®Google Scholar
• HardimanPPillayOCAtiomoWPolycystic ovary syndrome and endometrial carcinomaLancet200336193711810181212781553
   PubMed Web of Science ®Google Scholar
• GenazzaniARGadducciAGambaccianiMControversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert WorkshopClimacteric20014318119311588941
   PubMedGoogle Scholar
• BarryJAAziziaMMHardimanPJRisk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201420574875824688118
   PubMed Web of Science ®Google Scholar
• BroekmansFJKnauffEAHValkenburgOLavenJSEijkemansMJFauserBCJMPCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factorsBJOG2006113101210121716972863
   PubMed Web of Science ®Google Scholar
• HaoulaZSalmanMAtiomoWEvaluating the association between endometrial cancer and polycystic ovary syndromeHum Reprod20122751327133122367984
   PubMed Web of Science ®Google Scholar
• ChittendenBGFullertonGMaheshwariABhattacharyaSPolycystic ovary syndrome and the risk of gynaecological cancer: a systematic reviewReprod Biomed Online200919339840519778486
   PubMed Web of Science ®Google Scholar
• GiovannucciEMetabolic syndrome, hyperinsulinemia, and colon cancer: a reviewAm J Clin Nutr2007863s836s84218265477
   PubMed Web of Science ®Google Scholar
• IatrakisGZervoudisSSaviolakisAWomen younger than 50 years with endometrial cancerEur J Gynaecol Oncol200627439940017009635
   PubMed Web of Science ®Google Scholar
• ZucchettoASerrainoDPoleselJHormone-related factors and gynecological conditions in relation to endometrial cancer riskEur J Cancer Prev200918431632119554665
   PubMed Web of Science ®Google Scholar
• NiwaKImaiAHashimotoMA case-control study of uterine endometrial cancer of pre- and post-menopausal womenOncol Rep200071899310601598
   PubMed Web of Science ®Google Scholar
• DowlingRJGoodwinPJStambolicVUnderstanding the benefit of metformin use in cancer treatmentMBC Med2011933
   Google Scholar
• EngelmanJACantleyLCChemoprevention meets glucose controlCancer Prev Res20109910491052
   Web of Science ®Google Scholar
• WangYLXieYYuLMetformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cellsJ Steroid Biochem Mol Biol20111263–511312021168492
   PubMed Web of Science ®Google Scholar
• LegroRSZainoRJDemersLMThe effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndromeAm J Obstet Gynecol2007196440217403436
   PubMed Web of Science ®Google Scholar
• ShafieeMNKhanGAriffinRPreventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?Gynecol Oncol2014132124825324183733
   PubMed Web of Science ®Google Scholar
• PierpointTMcKeiguePMIsaacsAJWildSHJacobsHSMortality of women with polycystic ovary syndrome at long-term follow-upJ Clin Epidemiol19985175815869674665
   PubMed Web of Science ®Google Scholar
• DokrasACliftonSFutterweitWWildRIncreased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysisObstet Gynecol2011117114515221173657
   PubMed Web of Science ®Google Scholar
• CoffeySBanoGMasonHHealth-related quality of life in women with PCOS: a comparison with the general population using the PCOS questionnaire and the SF-36Gynecol Endocrinol2006222808616603432
   PubMed Web of Science ®Google Scholar
• BarnardLFerridayDGuentherNStraussBBalenAHDyeLQuality of life and psychological wellbeing in polycystic ovary syndromeHum Reprod20072282279228617537782
   PubMed Web of Science ®Google Scholar
• MoranLJDeeksAAGibson-HelmMETeedeHJPsychological parameters in the reproductive phenotypes of polycystic ovary syndromeHum Reprod20122772082208822493025
   PubMed Web of Science ®Google Scholar
• DokrasACliftonSFutterweitWWildRIncreased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysisFertil Steril201297122523022127370
   PubMed Web of Science ®Google Scholar
• LaggariVDiaremeSChristogiorgosSAnxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndromeJ Psychosom Obstet Gynaecol2009302838819533486
   PubMed Web of Science ®Google Scholar
• JonesGBenesKClarkTThe PCOS health-related quality of life questionnaire (PCSOQ): a validationHum Reprod200419237137714747184
   PubMed Web of Science ®Google Scholar
• BarryJAKuczmierczykARHardimanPJAnxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod20112692442245121725075
   PubMed Web of Science ®Google Scholar
• Harris-GlockerMDavidsonKKochmanLGuzickDHoegerKImprovement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metforminFertil Steril20109331016101919781696
   PubMed Web of Science ®Google Scholar
• ThomsonRLBuckleyJDLimSSLifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndromeFertil Steril20109451812181620004371
   PubMed Web of Science ®Google Scholar
• JedelEGustafsonDWaernMSex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndromePsychoneuroendocrinology201136101470147921549510
   PubMed Web of Science ®Google Scholar
• WeinerCLPrimeauMEhrmannDAAndrogens and mood dysfunction in women: comparison of women with PCOS to healthy controlsPsychosom Med200466335636215184695
   PubMed Web of Science ®Google Scholar
• ManssonMHolteJLandin-WilhelmsenKDahlgrenEJohanssonALandenMWomen with polycystic ovary syndrome are often depressed or anxious – a case control studyPsychoneuroendocrinology20083381132113818672334
   PubMed Web of Science ®Google Scholar
• OrioFTafuriDAscioneALifestyle changes in the management of adulthood and childhood obesityMinerva Endocrinol2014
   Web of Science ®Google Scholar
• PalombaSGiallauriaFFalboAStructured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot studyHum Reprod200823364265018158291
   PubMed Web of Science ®Google Scholar
• PalombaSFalboAGiallauriaFSix weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trialHum Reprod201025112783279120858697
   PubMed Web of Science ®Google Scholar
• BrownJFarquharCBeckJBoothroydCHughesEClomiphene and anti-oestrogens for ovulation induction in PCOS [review]Cochrane Database Syst Rev200974CD00224919821295
   PubMed Web of Science ®Google Scholar
• PalombaSFalboAZulloFManagement strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistanceCurr Opin Obstet Gynecol200921646547319809318
   PubMed Web of Science ®Google Scholar
• PalombaSAromatase inhibitors for ovulation inductionJ Clin Endocrinol Metab201510051742174725710566
   PubMed Web of Science ®Google Scholar
• FranikSKremerJANelenWLFarquharCAromatase inhibitors for subfertile women with polycystic ovary syndromeCochrane Database Syst Rev201421CD01028724563180
   PubMed Web of Science ®Google Scholar
• LegroRSZhangHEunice Kennedy Shriver NICHD Reproductive Medicine NetworkLetrozole or clomiphene for infertility in the polycystic ovary syndromeN Engl J Med2014371151463146425295506
   PubMedGoogle Scholar
• VitekWAlurSHoegerKMOff-label drug use in the treatment of polycystic ovary syndromeFertil Steril2015103360561125726702
   PubMed Web of Science ®Google Scholar
• PalombaSFalboAZulloFOrioFJrEvidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive reviewEndocr Rev200930115019056992
   PubMed Web of Science ®Google Scholar
• CassinaMDonàMDi GianantonioELittaPClementiMFirst-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysisHum Reprod Update201420565666924861556
   PubMed Web of Science ®Google Scholar
• PalombaSFalboALa SalaGBEffects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trialsBJOG2013120326727623194199
   PubMed Web of Science ®Google Scholar
• MitraSNayakPKAgrawalSLaparoscopic ovarian drilling: an alternative but not the ultimate in the management of polycystic ovary syndromeJ Nat Sci Biol Med201561404825810633
   PubMedGoogle Scholar
• BayramNvan WelyMvan Der VeenFRecombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndromeCochrane Database Syst Rev200112CD00212111406034
   PubMedGoogle Scholar
• Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupConsensus on infertility treatment related to polycystic ovary syndromeHum Reprod200823346247718308833
   PubMed Web of Science ®Google Scholar
• BelosiCSelvaggiLApaRIs the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?Hum Reprod200621123108311517053004
   PubMed Web of Science ®Google Scholar
• AbbottDHTarantalAFDumesicDAFetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeysAm J Perinatol2009719776784
   Google Scholar
• EhrmannDAPolycystic ovary syndromeN Engl J Med2005352121223123615788499
   PubMed Web of Science ®Google Scholar
• HurdWWAbdel-RahmanMYIsmailSAAbdellahMASchmotzerCLSoodAComparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndromeFertil Steril20119641043104721813121
   PubMed Web of Science ®Google Scholar
• LerchbaumESchwetzVGiulianiAObermayer-PietschBAssessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening methodHum Reprod20132892537254423756702
   PubMed Web of Science ®Google Scholar
• Velling MagnussenLMummHAndersenMGlintborgDHemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndromeFertil Steril20119651275128021982282
   PubMed Web of Science ®Google Scholar
• BrohallGSchmidtCBehreCJHultheJWikstrandJFagerbergBAssociation between impaired glucose tolerance and carotid atherosclerosis: a study in 64-year-old women and a meta-analysisNutr Metab Cardiovasc Dis200919532733319097767
   PubMed Web of Science ®Google Scholar
• RosenzweigJLFerranniniEGrundySMPrimary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab200893103671368918664543
   PubMed Web of Science ®Google Scholar
• MoscaLGuidelines for prevention of cardiovascular disease in women: a summary of recommendationsPrev Cardiol200710Suppl 4192517917527
   PubMedGoogle Scholar
• TimmermansAOpmeerBCKhanKSEndometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysisObstet Gynecol2010116116016720567183
   PubMed Web of Science ®Google Scholar
• KossLGSchreiberKOberlanderSGMoussourisHFLesserMDetection of endometrial carcinoma and hyperplasia in asymptomatic womenObstet Gynecol19846411116738931
   PubMed Web of Science ®Google Scholar
• SmithRAvon EschenbachACWenderRACS Prostate Cancer Advisory CommitteeACS Colorectal Cancer Advisory CommitteeACS Endometrial Cancer Advisory CommitteeAmerican Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001–testing for early lung cancer detectionCA Cancer J Clin2001511387511577479
   PubMed Web of Science ®Google Scholar
• MoranLJHutchisonSKNormanRJTeedeHJLifestyle changes in women with polycystic ovary syndromeCochrane Database Syst Rev20112CD007506
   Google Scholar
• MoranLJPasqualiRTeedeHJHoegerKMNormanRJTreatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome SocietyFertil Steril20099261966198219062007
   PubMed Web of Science ®Google Scholar
• KnowlerWCBarrett-ConnorEFowlerSEDiabetes Prevention Program Research GroupReduction in the incidence of type 2 diabetes with lifestyle intervention or metforminN Engl J Med2002346639340311832527
   PubMed Web of Science ®Google Scholar
• OrioFMuscogiuriGPalombaSCould the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of conceptEur J Clin Nutr Epub201541
   Web of Science ®Google Scholar
• DomecqJPPrutskyGMullanRJLifestyle modification programs in polycystic ovary syndrome: Systematic review and meta-analysisJ Clin Endocrinol Metab201398124655466324092832
   PubMed Web of Science ®Google Scholar
• HarrisonCLLombardCBMoranLJTeedeHJExercise therapy in polycystic ovary syndrome: a systematic reviewHum Reprod Update201117217118320833639
   PubMed Web of Science ®Google Scholar
• Escobar-MorrealeHFBotella-CarreteroJIAlvarez-BlascoFSanchoJSan MillánJLThe polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgeryJ Clin Endocrinol Metabol2005901263646369
   PubMed Web of Science ®Google Scholar
• TeedeHJMissoMLDeeksAAAssessment and management of polycystic ovary syndrome: summary of an evidence-based guidelineMed J Aust20111956S65S11221929505
   PubMed Web of Science ®Google Scholar
• VelazquezEMMendozaSHamerTSosaFGlueckCJMetformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancyMetabolism19944356476548177055
   PubMed Web of Science ®Google Scholar
• TsilchorozidouTOvertonCConwayGSThe pathophysiology of polycystic ovary syndromeClin Endocrinol (Oxf)200460111714678281
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis-RuifrokAEKuchenbeckerWKHoekAMiddletonPNormanRJInsulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysisHum Reprod Update2009151576818927072
   PubMed Web of Science ®Google Scholar
• TangTLordJMNormanRJYasminEBalenAHInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiroinositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityCochrane Database Syst Rev20125CD00305322592687
   PubMed Web of Science ®Google Scholar
• CostelloMShresthaBEdenJSjoblomPJohnsonNInsulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndromeCochrane Database Syst Rev20071CD00555217253562
   PubMed Web of Science ®Google Scholar
• LiXJYuYXLiuCQMetformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysisClin Endocrinol (Oxf)201174333233921050251
   PubMed Web of Science ®Google Scholar
• TangTLJNormanRJYasminEBalenAHInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityCochrane Database Syst Rev20101CD00305320091537
   PubMed Web of Science ®Google Scholar
• NissenSEWolskiKRosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortalityArch Int Med2010170141191120120656674
   PubMed Web of Science ®Google Scholar
• GambineriASempleRKForlaniGMonogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metforminEur J Endocrinol2008159334735318728124
   PubMed Web of Science ®Google Scholar
• TalbottEClericiABergaSLAdverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control studyJ Clin Epidemiol19985154154229619969
   PubMed Web of Science ®Google Scholar